Back to Search
KATHERINE TUTTLE, MD
Allergy & Immunology Physician
NPI: 1053758201IndividualAccepts Medicare
Specialties, Licenses & Credentials
Allergy & Immunology (Internal Medicine) Physician
Internal Medicine — Allergy & Immunology
Code: 207RA0201X
305125(NY)
Pediatrics Physician
Pediatrics
Code: 208000000X
273244(MA)
Pediatric Allergy/Immunology Physician
Pediatrics — Pediatric Allergy/Immunology
Code: 2080P0201X
305125(NY)
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
273244(MA)
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.
PMID 18781061·Am J Nephrol·2009
7-preclinical
More is not always better: intensive glycemic control in type 2 diabetes.
PMID 19101398·Am J Kidney Dis·2009
8-other
Could renin inhibition be the next step forward in the treatment of diabetic kidney disease?
PMID 18838970·Nat Clin Pract Endocrinol Metab·2009
8-other
Reovirus activates transforming growth factor beta and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection.
PMID 19279118·J Virol·2009
7-preclinical
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.
PMID 19577347·Am J Kidney Dis·2009
8-other
Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury?
PMID 18695383·Curr Opin Nephrol Hypertens·2008
6-review
Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial).
PMID 18489927·Am J Cardiol·2008
4-observational
Protein kinase C-beta inhibition for diabetic kidney disease.
PMID 18977550·Diabetes Res Clin Pract·2008
6-review
Tissue microarrays as a platform for proteomic investigation.
PMID 16953460·J Mol Histol·2007
7-preclinical
The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD.
PMID 17170547·Blood Purif·2007
8-other
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
PMID 17229944·Diabetes Care·2007
2-rct
Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.
PMID 17699475·Clin J Am Soc Nephrol·2007
4-observational
Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?
PMID 18177587·Curr Hypertens Rep·2007
6-review
Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy.
PMID 17693752·Curr Opin Nephrol Hypertens·2007
6-review
NKF releases new KDOQI guidelines for diabetes and CKD.
PMID 16859230·Nephrol News Issues·2006
8-other
A causal role for uric acid in fructose-induced metabolic syndrome.
PMID 16234313·Am J Physiol Renal Physiol·2006
7-preclinical
Implications of chronic kidney disease for dietary treatment in cardiovascular disease.
PMID 16825032·J Ren Nutr·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- STRONG MEMORIAL HOSPITAL
ROCHESTER, NY 14642 - Phone
- (585) 276-7190
Quick Facts
- NPI
- 1053758201
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile